Hey HAE Hereditary Angioedema Blog: Connect. Ask. Share.
FIRAZYR is a medicine used to treat acute attacks of hereditary angioedema (HAE) in adults 18 years of age and older.

Day by Day

Guidance Down the Insurance Road with OnePath®

Published on May 27, 2015 in Day by Day

For my husband, David, and me, having to deal with our medical insurance company can sometimes be scary, which is funny, because I am employed in the insurance industry. But when my husband’s treating HAE physician first made us aware of FIRAZYR® (icatibant injection), a medicine approved to treat acute hereditary angioedema (HAE) attacks in adults 18 years of age and older, we immediately worried about the cost and whether or not our insurance company would agree to cover the medication. We wanted to have the on-demand therapy of FIRAZYR at home for David to administer at the onset of an HAE attack, but we were afraid to get our hopes up.   

 

Very shortly after being prescribed FIRAZYR, we received a phone call from a Case Manager at OnePath®. The Case Manager asked about our medical insurance information and then contacted our insurance company to determine if they would cover the treatment. When he called us back to say that David was eligible to receive FIRAZYR, while that was good to hear, we expressed concern about the cost of the co-pay our insurance requires. Our Case Manager explained that we might be eligible for OnePath’s co-payment assistance program, and I am happy to report that we were, indeed, eligible for the co-pay assistance, which has really helped us. Upon David’s physician’s request, OnePath also arranged for a home healthcare nurse to come to our house to teach David how to self-administer FIRAZYR.

 

While our OnePath Case Manager helps us in many ways, my husband and I make sure to do our part. We have kept a diary of my husband’s HAE attacks and FIRAZYR injections—just in case we need to document to the insurance company that my husband truly needs FIRAZYR.

 

In this ever-changing medical insurance environment, which can be overwhelming for me, I feel it is very important for us to stay ahead of the game, and working with OnePath really helped make David’s transition to FIRAZYR go smoothly. It feels great that we have the opportunity to work with our Case Manager, who always seems willing to help.

 

--Stacey

 

HAE differs for everyone. Hear from a Shire Ambassador at an event near you. Click here for more information.

Add Comment


The information on this page is owned and controlled by Shire. All submissions will be reviewed and must be approved by Shire before being posted. Comments that do not directly relate to the topic, are factually inaccurate or misleading, or are spam, inappropriate, use profanity or are defamatory will not be posted.

Please keep your comments respectful, appropriate and do not reference any product names or product information. We will not post comments that include drug names or descriptions. Please note that Shire may choose not to post, or may remove, a comment for any reason at any time. Comments on the page from members of the public do not necessarily reflect the views of Shire and Shire does not endorse any content added by other users.

We are required to record and handle the submitted comments in a specific manner to monitor the safety of our product. If you have experienced a side effect or have a complaint specific to a Shire product, please contact your healthcare provider. In addition, we encourage you to report the event to us by calling +1-800 828-2088 or +1-888-300-6414, where someone is available to speak with you.

The information on this page is intended for residents of the United States only and is not meant to substitute for the advice provided by a medical professional. Always consult a physician if you have health concerns.

What is FIRAZYR?

FIRAZYR is prescribed to treat acute HAE attacks in adults 18 years of age and older.

Get the facts »